SCHEMBL7227791

SCHEMBL7227791

O=[N+]([O-])c1ccc(CN2CC=CCC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.74
KDM4E B2RXH2 3/20 0.59
ALDH1A1 P00352 3/20 0.57
KCNJ1 P48048 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
LMNA P02545 1/20 0.57
MAPT P10636 1/20 0.57
KCNH2 Q12809 1/20 0.51
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
BACE1 P56817 1/20 0.50
NPC1 O15118 1/20 0.49
NR2F2 P24468 1/20 0.49
MAPK1 P28482 1/20 0.49
RAB9A P51151 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8661674 0.98 MAOA (0.72) MAOAKDM4EALDH1A1KCNJ1SMN1; SMN2
SCHEMBL7232102 0.89 KDM4E (0.63) MAOAKDM4EALDH1A1KCNJ1SMN1; SMN2
SCHEMBL6324876 0.85 MAOA (1.00) MAOAKCNJ1KCNH2HRH3
SCHEMBL23832519 0.82 KDM4E (0.69) MAOAKDM4EALDH1A1KCNJ1SMN1; SMN2
SCHEMBL2206628 0.78 KDM4E (0.73) KDM4EALDH1A1KCNJ1SMN1; SMN2LMNA
SCHEMBL3156886 0.78 KDM4E (0.73) KDM4EALDH1A1KCNJ1SMN1; SMN2LMNA
SCHEMBL8329627 0.77 KDM4E (0.71) KDM4EALDH1A1KCNJ1SMN1; SMN2LMNA
SCHEMBL3143167 0.77 KDM4E (0.71) KDM4EALDH1A1KCNJ1SMN1; SMN2LMNA
SCHEMBL1805498 0.77 KDM4E (0.71) KDM4EALDH1A1KCNJ1SMN1; SMN2LMNA
SCHEMBL5626457 0.76 ALDH1A1 (0.74) KDM4EALDH1A1KCNJ1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed
US-5807857-A Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists MERCK SHARP & DOHME LTD. (GB) 1998-09-15 US disclosed
EP-0759918-A1 PIPERAZINE, PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES OF INDOL-3-YLALKYL AS 5-HT1D-ALPHA AGONISTS MERCK SHARP & DOHME LTD. (GB) 1997-03-05 EP disclosed
WO-1995032196-A1 PIPERAZINE, PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES OF INDOL-3-YLALKYL AS 5-HT1D-ALPHA AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1995-11-30 WO disclosed